Knocking down ERα36 in tamoxifen-resistant breast cancer cell lines induces downregulation of EGFR both in mRNA level and protein level, by which restoring the sensitivity of ER-positive breast cancer to tamoxifen [8]. The gene discussed is EGFR; the disease is breast carcinoma.